How RedMontMed works

RedMontMed brings together independently researched, evidence-based information to support people facing difficult health decisions across Canada, the USA, the UK, the European Union, the EEA and Switzerland. We understand that uncertainty after a diagnosis can be overwhelming, and that clear, trustworthy information can make conversations with healthcare professionals feel more grounded and less frightening.

We are not a medical directory, a referral service, or a clinical decision-support tool. Our purpose is to offer structured, transparent information that helps patients feel more prepared, informed and supported when speaking with their own clinicians. All information on this platform is for informational purposes only and must never be used as a substitute for professional medical judgement.

RedMontMed was built by someone who has been on the other side of a serious diagnosis — who knows what it feels like to need the right answer fast, and to feel lost in a sea of conflicting, commercially influenced information. That experience is the reason this platform exists and the reason it operates the way it does.

RedMontMed identifies and presents clinicians with great care, using transparent, evidence-based criteria. Our goal is to help patients feel confident that the clinicians listed are genuinely among the most relevant and accomplished in their field for a specific condition, in a specific city, across Canada, the USA, the UK, the EU, the EEA and Switzerland.

We evaluate clinicians using the following criteria, applied in order of importance:

1. 1
   Peer-reviewed research impact

   Depth, volume and influence of publications specific to the condition, including journal impact factors and citation strength where measurable.
2. 2
   Leadership in major clinical work

   Roles in significant clinical trials, national guideline committees, or specialist society working groups relevant to the condition.
3. 3
   Seniority and institutional standing

   Preference for consultants and attending physicians at recognised academic medical centres with a clear, documented specialism in the relevant condition.
4. 4
   International recognition

   Invited lectureships, society presidencies, named awards, or editorial board positions in respected specialist journals.
5. 5
   Surgical excellence (surgeons)

   Case volume and complexity at high-volume centres, use of advanced or minimally invasive techniques, and contributions to surgical training at national or international level.

Only clinicians who are genuinely among the most relevant in their country for a specific condition are included. We never expand lists with less notable names to appear more comprehensive. Each search returns a maximum of three most relevant physicians and three most relevant surgeons — because quality matters more than volume.

RedMontMed ranks treatments using a strict evidence hierarchy, prioritising reproducible clinical outcomes and guideline-level validation across all six jurisdictions. Each therapy is evaluated using the following criteria, applied in descending order of evidentiary strength:

1. 1
   Guideline-level endorsement

   Inclusion in current, authoritative clinical guidelines. Guideline presence indicates consensus-level validation based on high-quality evidence synthesis.
2. 2
   Efficacy in controlled trials

   Magnitude and statistical robustness of survival benefit or clinically meaningful endpoints supported by published randomised controlled trials or peer-reviewed meta-analyses.
3. 3
   Real-world adoption at specialist centres

   Utilisation rates at high-volume academic or specialist institutions within the relevant country, reflecting translational viability and clinician confidence.
4. 4
   Innovation supported by late-phase data

   Emerging therapies are included only when supported by strong Phase 2 or Phase 3 trial evidence demonstrating reproducible efficacy and safety, and only when genuinely accessible within the relevant jurisdiction.

Treatments that lack sufficient evidence, have not achieved guideline recognition, or are not accessible in the relevant country are excluded.

RedMontMed systematically identifies active and recruiting clinical trials using a structured, multi-registry approach covering all six jurisdictions. Our process prioritises accuracy, verifiability and alignment with internationally recognised trial-reporting standards.

1. 1
   Primary registry extraction

   Trials are identified from authoritative public registries and synced automatically on a regular schedule to ensure currency.
2. 2
   Eligibility filtering

   Only trials that are actively recruiting or enrolling by invitation are included. Suspended, withdrawn or terminated trials are excluded.
3. 3
   Structured data extraction

   For each trial we extract phase, recruitment status, sponsor type, lead centre, participating sites, intervention type, and primary endpoints.
4. 4
   Eligibility summary

   Inclusion and exclusion criteria are summarised in plain English to help patients understand whether a trial may be relevant to their situation.
5. 5
   Verification and traceability

   Registry URLs are provided wherever available, enabling patients and clinicians to verify details directly at the source.

Patient support groups, charities and helplines are listed on the basis of their relevance to the specific condition and their availability in the relevant country or region. We prioritise verified charities, established patient advocacy organisations and specialist clinics with documented programmes for the condition.

All charities are listed free of charge, always. No support organisation can pay for a position or preferential placement. International organisations are included alongside local groups where relevant. Contact details are drawn from public sources and should be verified directly before making contact.

RedMontMed uses AI-assisted research powered by Anthropic Claude to identify, organise and rank information from publicly available sources. The AI assists with identifying relevant clinicians from academic and hospital publications, summarising eligibility criteria for clinical trials in plain English, ranking results according to the merit-based criteria described above, and generating clear, jargon-free summaries of search results for patients.

The AI does not make clinical decisions. It does not provide medical advice. It is a research and organisation tool that works within the strict criteria described on this page. All AI-generated content is subject to human review before publication.

Search data sent to the AI consists only of the medical condition and country searched. No personal data, email addresses or identifying information is ever sent to the AI system.

Specialist results (physicians, surgeons, treatments, support groups) are AI-researched fresh on the first search for any condition + location, then cached for 7 days. Repeat searches within that window return instantly. Clinical trial data is always fetched live at the moment of search — never cached — from ClinicalTrials.gov and, for EU/EEA countries, from CTIS (the EU Clinical Trials Information System, which replaced the legacy EU Clinical Trials Register as the mandatory EU registry from January 2023).

We publish these limitations because honesty about what RedMontMed cannot do is as important as describing what it can.

• Contact details are AI-generated from public sources and have not been individually verified by RedMontMed. Always confirm contact details directly through official hospital, clinic or regulatory websites before making contact.
• Licensing status is not verified. Always independently confirm that any clinician is currently licensed and in good standing with the appropriate regulatory authority — GMC (UK), state medical boards (USA), provincial colleges (Canada), national medical councils (EU/EEA), FMH/Medregom (Switzerland).
• Trial recruiting status may change. Clinical trial information may not always reflect the most current recruiting status. Always verify directly via the registry link provided.
• This is not medical advice. RedMontMed does not provide medical advice, clinical guidance, personalised recommendations or endorsements of any kind. All content is informational only. All decisions about diagnosis, treatment or care must be made in consultation with a qualified healthcare professional.
• Completeness is not guaranteed. Publicly available data may be incomplete, outdated or inconsistent across sources. RedMontMed's outputs should be treated as a structured starting point, not a definitive or exhaustive resource.